European Respiratory Review

提交稿件即表示一旦稿件被接受发表,所有作者将授予ERS一项全球性、独占性的许可,以制作、出版、销售、分发和提供其文章,并可在印刷、数字及其他媒体格式(包括摘要和补充材料)中进一步转授权,以便ERS获得最大限度的国际版权保护并尽可能广泛地传播文章。 模型中文摘要

Submission of the manuscript implies that if and when it is accepted for publication, all authors will grant to ERS a worldwide and exclusive licence to produce, publish, sell, distribute and make available, and to further sub-licence their article in print, digital and other media formats, including abstracts and supplementary material. This enables ERS to ensure maximum international copyright p…

欧洲呼吸学会将根据作者选择的选项,按照以下两种知识共享许可之一发表被接受的稿件:CC-BY许可允许任何人为商业或非商业目的分享、重用或改编稿件,但须注明原始出处并标明更改;CC-BY-NC许可仅允许非商业目的的分享、重用或改编,同样须注明出处并标明更改。 模型中文摘要

The European Respiratory Society will publish accepted manuscripts under the terms of one of the following Creative Commons licences, depending upon the option chosen by the author. Creative Commons Attribution 4.0 International (‘CC-BY’) - under this licence, anyone may share, reuse or adapt the manuscript for any commercial or non-commercial purpose, providing they give credit to the original so…

《欧洲呼吸评论》的文章采用单盲同行评审,如对主编决定有异议,可访问ERS的同行评审与反驳页面了解更多信息。 模型中文摘要

European Respiratory Review articles are subject to single-anonymised peer review. To find out more about ERS peer review processes and what to do if you disagree with a Chief Editor’s decision, visit our Peer review and rebuttals page.

ERR文章作者有权在发表后立即将最终发表版本存入机构或其他公共存储库,但须遵守相关知识共享许可条款;对于获得Coalition S或UKRI资助的文章,作者保留以CC-BY许可无禁期存档同行评审后“作者接受稿”的权利。 模型中文摘要

The European Respiratory Society will publish accepted manuscripts under the terms of the Creative Commons licence chosen by the author at acceptance (or by their institution in the case of an institutional open access arrangement). Authors of ERR articles are entitled to deposit the final published version of their manuscripts in an institutional (or other) repository for public archiving immedia…